|
| 产地 | 中国 |
| 品牌 | Chemstan |
| 货号 | LC-01 |
| 用途 | 中间体 |
| 包装规格 | 20mg |
| 纯度 | 98%% |
| CAS编号 | 1187594-09-7 |
| 是否进口 | 否 |
联合知名大学科研院所及企业开发药食两用植物标准品和天然植物有效单体，主打中药对照品/标准品/天然植物有效单体，小分子化合物库，药物杂质。所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。
| 常用名 | 巴瑞克替尼 | 英文名 | Baricitinib |
|---|---|---|---|
| CAS号 | 1187594-09-7 | 分子量 | 371.417 |
| 密度 | 1.6±0.1 g/cm3 | 沸点 | 707.2±70.0 °C at 760 mmHg |
| 分子式 | C16H17N7O2S | 熔点 | N/A |
| MSDS | N/A | 闪点 | 381.5±35.7 °C |
Baricitinib是选择性，可口服的 JAK1 和 JAK2 抑制剂，IC50 分别为5.9 nM 和 5.7 nM。
Fields of Application :
Baricitinib is a selective JAK1 and JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM, ~70 and ~10-fold selective versus JAK3 and Tyk2, no inhibition to c-Met and Chk2. Phase 3.
| CAS Number: | 1187594-09-7 |
| Purity: | >98% |
| Molecular Weight: | 371.4 |
| Molecular Formula: | C16H17N7O2S |
Quality Control: HPLC、NMR、 LC/MS(Please contact us to get the QC report)
| Synonyms: | Baricitinib, INCB28050, LY3009104. |
| Chemical Name: | |
| Storage: | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
Note: Products for research use only, not for human use
Description:
Baricitinib, also known as INCB028050 or LY3009104, is a selective orally bioavailable JAK1/JAK2 inhibitor with nanomolar potency against JAK1 (5.9 nM) and JAK2 (5.7 nM). INCB028050 inhibits intracellular signaling of multiple proinflammatory cytokines including IL-6 and IL-23 at concentrations <50 nM. Significant efficacy, as assessed by improvements in clinical, histologic and radiographic signs of disease, was achieved in the rat adjuvant arthritis model with doses of INCB028050 providing partial and/or periodic inhibition of JAK1/JAK2 and no inhibition of JAK3. Diminution of inflammatory Th1 and Th17 associated cytokine mRNA levels was observed in the draining lymph nodes of treated rats. INCB028050 was also effective in multiple murine models of arthritis, with no evidence of suppression of humoral immunity or adverse hematologic effects. These data suggest that fractional inhibition of JAK1 and JAK2 is sufficient For significant activity in autoimmune disease models.For the detailed information of Baricitinib (INCB28050, LY3009104), the solubility of Baricitinib (INCB28050, LY3009104) in water, the solubility of Baricitinib (INCB28050, LY3009104) in DMSO, the solubility of Baricitinib (INCB28050, LY3009104) in PBS buffer, the animal experiment (test) of Baricitinib (INCB28050, LY3009104), the cell expriment (test) of Baricitinib (INCB28050, LY3009104), the in vivo, in vitro and clinical trial test of Baricitinib (INCB28050, LY3009104), the EC50, IC50,and Affinity of Baricitinib (INCB28050, LY3009104), Please contact DC Chemicals.
